0001627223-21-000042.txt : 20210830
0001627223-21-000042.hdr.sgml : 20210830
20210830185248
ACCESSION NUMBER: 0001627223-21-000042
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210827
FILED AS OF DATE: 20210830
DATE AS OF CHANGE: 20210830
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Shelton David C
CENTRAL INDEX KEY: 0001645179
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36794
FILM NUMBER: 211224947
MAIL ADDRESS:
STREET 1: C/O THE CHEMOURS COMPANY
STREET 2: 1007 MARKET STREET
CITY: WILMINGTON
STATE: DE
ZIP: 19898
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Chemours Co
CENTRAL INDEX KEY: 0001627223
STANDARD INDUSTRIAL CLASSIFICATION: CHEMICALS & ALLIED PRODUCTS [2800]
IRS NUMBER: 464845564
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1007 MARKET STREET
CITY: WILMINGTON
STATE: DE
ZIP: 19801
BUSINESS PHONE: 302 773 1000
MAIL ADDRESS:
STREET 1: 1007 MARKET STREET
CITY: WILMINGTON
STATE: DE
ZIP: 19801
FORMER COMPANY:
FORMER CONFORMED NAME: Chemours Company, LLC
DATE OF NAME CHANGE: 20141205
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2021-08-27
0
0001627223
Chemours Co
CC
0001645179
Shelton David C
C/O THE CHEMOURS COMPANY
1007 MARKET STREET
WILMINGTON
DE
19898
0
1
0
0
SVP, GC & Corp. Secretary
Common Stock
2021-08-27
4
M
0
8689
18.45
A
72616.3979
D
Common Stock
2021-08-27
4
S
0
8689
35
D
63927.3979
D
Common Stock
2021-08-30
4
M
0
1065
18.45
A
64992.3979
D
Common Stock
2021-08-30
4
S
0
1065
35
D
63927.3979
D
Common Stock
71500
I
By Trust
Common Stock
492
I
By Spouse
Stock Option (Right to Buy)
18.45
2021-08-27
4
M
0
8689
0
D
2022-02-03
Common Stock
8689
10951
D
Stock Option (Right to Buy)
18.45
2021-08-30
4
M
0
1065
0
D
2022-02-03
Common Stock
1065
9886
D
The stock option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 10, 2021.
Includes directly owned shares, restricted stock units, and dividend equivalent units.
Shares were sold in multiple transactions at prices ranging from $35.00 to $35.01.
Option award was granted on February 4, 2015 with vesting in three equal annual installments beginning February 4, 2016.
/s/ Pauletta Brown, Attorney-in-Fact
2021-08-30